Cargando…

Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation

Microglial activation and inflammation are associated with progressive neuronal apoptosis in neurodegenerative disorders such as Parkinson’s disease (PD). γ-Aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system, has recently been shown to play an inhibitory ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jie, Huang, Dongping, Xu, Jing, Tong, Jiabin, Wang, Zishan, Huang, Li, Yang, Yufang, Bai, Xiaochen, Wang, Pan, Suo, Haiyun, Ma, Yuanyuan, Yu, Mei, Fei, Jian, Huang, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620555/ https://www.ncbi.nlm.nih.gov/pubmed/26499517 http://dx.doi.org/10.1038/srep15720

Ejemplares similares

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease
por: Huang, Dongping, et al.
Publicado: (2019)

Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins
por: Callizot, Noëlle, et al.
Publicado: (2019)

Comprehensive Analysis of Neurotoxin-Induced Ablation of Dopaminergic Neurons in Zebrafish Larvae
por: Kalyn, Michael, et al.
Publicado: (2019)

Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
por: Jiang, Lulu, et al.
Publicado: (2016)

Tiagabine: efficacy and safety in partial seizures – current status
por: Bauer, Jürgen, et al.
Publicado: (2008)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
por: Wang, Qingshan, et al.
Publicado: (2012)

DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65
por: Lin, Zixuan, et al.
Publicado: (2021)

Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation
por: Zhang, Ruiping, et al.
Publicado: (2011)

Classification of High-Activity Tiagabine Analogs by Binary QSAR Modeling
por: Jurik, Andreas, et al.
Publicado: (2013)

Tiagabine treatment in kainic acid induced cerebellar lesion of dystonia rat model
por: Wang, Tsui-chin, et al.
Publicado: (2016)

NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
por: Liu, Zhaolin, et al.
Publicado: (2023)

Insights into the interaction mechanism between tiagabine hydrochloride and two serum albumins
por: Zhuo, Weiling, et al.
Publicado: (2018)

Analysis of Different Binding Modes for Tiagabine within the GAT-1 Transporter
por: Łątka, Kamil, et al.
Publicado: (2022)

Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1
por: Zafar, Sadia, et al.
Publicado: (2020)

GPR4 Knockout Improves the Neurotoxin-Induced, Caspase-Dependent Mitochondrial Apoptosis of the Dopaminergic Neuronal Cell
por: Haque, Md Ezazul, et al.
Publicado: (2020)

Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures
por: Knappe, Evelyn, et al.
Publicado: (2023)

JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss
por: Wang, Qing, et al.
Publicado: (2018)

Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson’s Disease Models
por: Huang, Bingxu, et al.
Publicado: (2017)

Inhibition of Nigral Microglial Activation Reduces Age-Related Loss of Dopaminergic Neurons and Motor Deficits
por: Wang, Tzu-Feng, et al.
Publicado: (2022)

Pairwise structural comparison of tiagabine analogs gives new insights into their protein binding modes
por: Zdrazil, Barbara, et al.
Publicado: (2013)

Tiagabine Improves Hippocampal Long-Term Depression in Rat Pups Subjected to Prenatal Inflammation
por: Rideau Batista Novais, Aline, et al.
Publicado: (2014)

Taurine protects dopaminergic neurons in a mouse Parkinson’s disease model through inhibition of microglial M1 polarization
por: Che, Yuning, et al.
Publicado: (2018)

Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
por: Song, Dae-Yong, et al.
Publicado: (2013)

Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo
por: Lee, Shou-Lun, et al.
Publicado: (2021)

P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo
por: Gu, Chao, et al.
Publicado: (2017)

Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death
por: Wang, Yi-Ting, et al.
Publicado: (2017)

Tiagabine and zonisamide differentially regulate the glial properties in an astrocyte-microglia co-culture model of inflammation
por: Ismail, Fatme Seval, et al.
Publicado: (2023)

Cyanobacterial Neurotoxin Beta-Methyl-Amino-l-Alanine Affects Dopaminergic Neurons in Optic Ganglia and Brain of Daphnia magna
por: Brooke-Jones, Megan, et al.
Publicado: (2018)

Secreted miR-34a in astrocytic shedding vesicles enhanced the vulnerability of dopaminergic neurons to neurotoxins by targeting Bcl-2
por: Mao, Susu, et al.
Publicado: (2015)

α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin
por: Lieberman, Ori J., et al.
Publicado: (2017)

Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival
por: Kang, Jongkyun, et al.
Publicado: (2023)

Sex, Pramipexole and Tiagabine Affect Behavioral and Hormonal Response to Traumatic Stress in a Mouse Model of PTSD
por: Malikowska-Racia, Natalia, et al.
Publicado: (2021)

Necrostatin-1 protection of dopaminergic neurons
por: Wu, Jing-ru, et al.
Publicado: (2015)

Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson’s Disease Mouse Model
por: Ruan, Zhengzheng, et al.
Publicado: (2022)

Olfactory Sensory Activity Modulates Microglial-Neuronal Interactions during Dopaminergic Cell Loss in the Olfactory Bulb
por: Grier, Bryce D., et al.
Publicado: (2016)

Protective effect of alpha-synuclein knockdown on methamphetamine-induced neurotoxicity in dopaminergic neurons
por: Tai, Yunchun, et al.
Publicado: (2014)

Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis
por: Huang, Zifeng, et al.
Publicado: (2021)

[(11)C]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels
por: Frankle, W. Gordon, et al.
Publicado: (2012)

Insights into binding events of GABA- and Tiagabine- analogues in the Gamma-Aminobutyric Acid Transporter 1 by means of Molecular Modelling
por: Zdrazil, Barbara, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6u2jka86qrj9s25lce5uicc732